Trump Reclassifies Marijuana to Schedule III: Impacts on Research and Business

Executive Order and Reclassification

• 🚀 President Trump signed an executive order reclassifying marijuana from Schedule I to Schedule III, a move that took 10 years of advocacy.
• 💡 The reclassification is seen as a message to emphasize the potential for medical research by moving marijuana away from classifications like heroin and ecstasy.

Business and Tax Implications

• 🎯 The reclassification addresses the issue of marijuana being wrongly perceived as having high addiction potential and no medical benefit.
• 💰 A significant impact is the reduction of federal tax rates for legal cannabis businesses from approximately 80% to 21%, making it possible for them to be profitable.
• ⚠️ This change aims to keep the legal market open, prevent illicit operators from benefiting, and keep cannabis away from children.

Research and Medical Benefits

• 🔬 Schedule I classification severely restricted research, while Schedule III opens the door for significantly more research into cannabis and its potential benefits.
• 🧠 The decision was influenced by the harm reduction from opioids and the benefits observed from CBD and THC products in treating serious health issues.

Business Strategy Shift

• 📈 Scotts Miracle-Gro's CEO, Jim Hagedorn, announced plans to combine its Hawthorne subsidiary (cannabis growing supplies) with a dedicated Pure Play cannabis company next year.
• 📊 This move is driven by investor interest in the more consistent free cash flow from lawn and garden businesses, while still allowing the company to benefit from the cannabis equity separately.